Gregory Mullen
Company: Ariceum Therapeutics
Job title: Chief Operating Officer
Seminars:
Understanding Radionuclide Auger Therapy to Examine Its Use & Advantages 1:30 pm
• Identifying which radioisotopes can be used for Auger therapy • Overview of Auger therapies to date • Examining Auger PARP inhibitor radionuclide therapyRead more
day: Conference Day 2